Alef and Casa Systems Join Forces to Unlock Opportunity for Mobile Private Networks
February 26, 2024 02:00 ET
|
Casa Systems, Inc.
NEW YORK and ANDOVER, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alef, a leader in mobile connectivity solutions, and Casa Systems, provider of cloud-native network solutions serving communications...
Virtual Evolved Packet Core Market revenue to hit USD 30 Billion by 2035, says Research Nester
August 17, 2023 05:00 ET
|
Research Nester
New York, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The global virtual evolved packet core (vEPC) market size is projected to expand at ~26% CAGR between 2023 and 2035. The market is expected to garner a...
CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customers
March 07, 2023 12:49 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 07, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Precipio, Inc. (NASDAQ: PRPO), please note that the 5th paragraph should read...
Precipio continues to sign up and onboard HemeScreen™ customers
March 07, 2023 12:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 07, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) continues to convert its sales pipeline into HemeScreen customers, with an...
Precipio Signs Another Major HemeScreen™ Customer
January 11, 2023 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced another 4-year agreement with a new customer to bring HemeScreen™...
Precipio Signs Additional Major HemeScreen™ Customer
December 06, 2022 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced a 4-year agreement with a new customer to bring HemeScreen™...
Precipio Launches New 1-Step Technology for all HemeScreen Assays
August 16, 2022 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of its second generation of HemeScreen panels. Precipio’s...
Precipio to distribute HemeScreen® through Fisher Healthcare channel
July 20, 2022 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has entered into an agreement with Fisher Healthcare,...
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
April 26, 2022 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen,...
New York State Approves Precipio’s HemeScreen for POL clinical use
November 18, 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...